Jacksonville Doctor Working On A Vaccine That Could Prevent Breast, Ovarian, & Lung cancer
JACKSONVILLE, Fla. (WSVN) – A professor in Jacksonville said he’s closer to his dream of a vaccine to prevent breast, ovarian and some types of lung cancer.
According to a FOX 13 report, immunology professor Dr. Keith Knutson said his dream would be to develop a vaccine to prevent cancer development.
“The hope is we can develop vaccines before the development of cancer much in the way that we use a polio vaccine or a flu vaccine,” said Knutson to FOX 13.
His vaccine is called TPIV 200, which works to teach immune system T cells to recognize cancer cells as the enemy.
The CEO of TapImmune, who makes TPIV 200, Glynn Wilson said clinical trials have been in place since 2012, and are now in “phase II.”
Wilson says the results so far have been encouraging.
“The vaccine was safe and well tolerated, but more importantly, we saw robust T cell responses. It’s a robust and long acting response, the type of response we like to see,” Wilson said.